Mode
Text Size
Log in / Sign up
N/A Completed N=23 Randomized Single-blind Treatment

Recovery of Visual Acuity in People With Vestibular Deficits

Vestibular Neuronitis · Vestibular Neuronitis, Bilateral · Vestibular schwannoma
Source: ClinicalTrials.gov NCT00411216 ↗
Enrolled (actual)
23
Serious AEs
0.0%
Results posted
Jul 2014
Primary outcomePrimary: Change in Visual Acuity During Head Movement From Baseline to Discharge — 0.198; .296 LogMAR

Summary

The purpose of this study is to determine whether exercises relieve the symptoms of dizziness and imbalance in people with vestibular deficits and improves the ability to see clearly during head movements. We hypothesize that the performance of specific adaptation and substitution exercises will result in an improvement in visual acuity during head movements while those patients performing placebo exercises will show no improvement.

Outcome Measures

OutcomeResultp-value
PRIMARY
Change in Visual Acuity During Head Movement From Baseline to Discharge
0.198; .296
PRIMARY
Subjective Complaints: (All Pre- and Post-intervention):
SECONDARY
Disability Scale
SECONDARY
Activities Specific Balance Confidence Scale
SECONDARY
Symptoms Intensity for Dizziness, Oscillopsia, Disequilibrium
SECONDARY
Balance and Gait
SECONDARY
Fall Risk (Dynamic Gait Index)
SECONDARY
Eye Movements: Scleral Search Coil

Eligibility Criteria

Inclusion Criteria

  • Patient had to have either a unilateral vestibular or bilateral vestibular hypofunction defined as follows: Unilateral vestibular deficits were defined by a > 25% difference in slow phase eye velocity between right and left sides on either the caloric or rotary chair test. Bilateral vestibular deficits were defined included refixation saccades made in response to unpredictable head thrusts to the right and left, a gain < .1 on rotary chair step test and a peak slow phase eye movement of <5 degrees/sec during irrigation of each ear on bithermal water caloric testing
  • Healthy subjects with normal vestibular function test results
  • must be able to complete DVA test

Exclusion Criteria

  • Patients with central lesions will be omitted from the study because vestibular adaptation or other compensatory mechanisms may be compromised and
  • Patients with visual acuity when the head is stationary of 20/60 or worse.
  • Patients on medication that suppress or facilitate vestibular function will not be excluded from the study but data will be analyzed to assess the effect of medication.
  • Patient who do not understand the purpose of the study and what it involves
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00411216). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search